This inventor holds 1 USPTO granted patent. Top assignee: Celgene Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Guobin Miao: Innovator in MK2 Inhibitors
Introduction
Guobin Miao is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of MK2 inhibitors. His work is recognized for its potential applications in various therapeutic areas.
Latest Patents
Guobin Miao holds a patent titled "MK2 INHIBITORS AND USES THEREOF." This patent represents his innovative approach to targeting MK2, which is crucial in several biological processes. The patent showcases his expertise and commitment to advancing medical science.
Career Highlights
Miao is currently employed at Celgene Corporation, a leading biopharmaceutical company. His role at Celgene allows him to collaborate with other talented professionals in the industry. His career is marked by a focus on developing novel therapeutic strategies.
Collaborations
Throughout his career, Guobin Miao has worked alongside esteemed colleagues such as Xirui Hu and Lixin Qiao. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Guobin Miao is a distinguished inventor whose work on MK2 inhibitors has the potential to impact the pharmaceutical industry significantly. His contributions at Celgene Corporation and collaborations with fellow researchers highlight his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile